Clinical and Coronary Plaque Predictors of Atherosclerotic Nonresponse to Statin Therapy

JACC Cardiovasc Imaging

4 April Apr 2023 2 months ago
  • Andreini D, Conte E, Pontone G.

Statins reduce the incidence of major cardiovascular events, but residual risk remains. The study examined the determinants of atherosclerotic statin nonresponse.

Reference: Clinical and Coronary Plaque Predictors of Atherosclerotic Nonresponse to Statin Therapy. van Rosendael SE, van den Hoogen IJ, Lin FY, Andreini D, Al-Mallah MH, Budoff MJ, Cademartiri F, Chinnaiyan K, Choi JH, Conte E, Marques H, de Araújo Gonçalves P, Gottlieb I, Hadamitzky M, Leipsic JA, Maffei E, Pontone G, Raff GL, Shin S, Kim YJ, Lee BK, Chun EJ, Sung JM, Lee SE, Virmani R, Samady H, Stone PH, Min JK, Narula J, Shaw LJ, Chang HJ, van Rosendael AR, Bax JJ. JACC Cardiovasc Imaging. 2022 Nov 23:S1936-878X(22)00655-6.

Go to PubMed